4
Changes in Ownership
Sionna Therapeutics, Inc. Filed Acc 0001451612-25-000004
Director sold 78,693 shares at an average $30.08 ($2,367,473)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Booth Bruce Director | 2025-09-29 | Sale 10b5-1 | −54,637 | $30.09 | $1,644,027 | 2,831,656 | I |
| Booth Bruce Director | 2025-09-29 | Sale 10b5-1 | −11,468 | $30.09 | $345,072 | 796,259 | I |
| Booth Bruce Director | 2025-09-30 | Sale 10b5-1 | −10,239 | $30.06 | $307,784 | 2,821,417 | I |
| Booth Bruce Director | 2025-09-30 | Sale 10b5-1 | −2,149 | $30.06 | $64,599 | 794,110 | I |
| Booth Bruce Director | 2025-10-01 | Sale 10b5-1 | −165 | $29.95 | $4,942 | 2,821,252 | I |
| Booth Bruce Director | 2025-10-01 | Sale 10b5-1 | −35 | $29.95 | $1,048 | 794,075 | I |
| Open-market sales · 78,693 sh · avg $30.08 · $2,367,473 | |||||||
Loading xslF345X05/form4-10012025_101039.xml…